P05.47 Long-lasting response in spinal metastases from ALK rearranged Non-Small-Cell Lung Cancer treated with different ALK inhibitors

MLA

Pellerino, A., et al. “P05.47 Long-Lasting Response in Spinal Metastases from ALK Rearranged Non-Small-Cell Lung Cancer Treated with Different ALK Inhibitors.” Neuro-Oncology, vol. 20, Sept. 2018, pp. iii313-iii314. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0c1ec4dff77019fd8fca87107cbeb5ef&authtype=sso&custid=ns315887.

APA

Pellerino, A., Rudà, R., Franchino, F., Marchese, G., Bruno, F., Mo, F., & Soffietti, R. (2018). P05.47 Long-lasting response in spinal metastases from ALK rearranged Non-Small-Cell Lung Cancer treated with different ALK inhibitors. Neuro-Oncology, 20, iii313-iii314.

Chicago

Pellerino, A, R Rudà, F Franchino, G Marchese, F Bruno, F Mo, and R Soffietti. 2018. “P05.47 Long-Lasting Response in Spinal Metastases from ALK Rearranged Non-Small-Cell Lung Cancer Treated with Different ALK Inhibitors.” Neuro-Oncology 20 (September): iii313-iii314. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0c1ec4dff77019fd8fca87107cbeb5ef&authtype=sso&custid=ns315887.